BriaCell Therapeutics (BCTX) Net Income towards Common Stockholders (2021 - 2026)
BriaCell Therapeutics' Net Income towards Common Stockholders came in at -$7.16 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), compared with -$6.13 million a year earlier.
Powered by 
Analysis
BriaCell Therapeutics (BCTX) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Apr 30, 2026, BriaCell Therapeutics reported Net Income towards Common Stockholders of -$30.68 million; for FY2025 (ended Jul 31, 2025), it came in at -$26.31 million.
- Going back by fiscal year, Net Income towards Common Stockholders was -$4.79 million in FY2024, -$20.3 million in FY2023, -$26.84 million in FY2022 and -$13.82 million in FY2021.
- The five-year range for quarterly Net Income towards Common Stockholders is -$27.53 million (fiscal Q1 2022) to $11.16 million (fiscal Q4 2022).
- Business Quant data shows BCTX's Net Income towards Common Stockholders at -$7.22 million (Q2 2026), -$8.2 million (Q1 2026) and -$8.09 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | BriaCell Therapeutics | 29.29 Mn | 28.64 Mn | - | -7.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -7.16 Mn |
| Jan 31, 2026 | -7.22 Mn |
| Oct 31, 2025 | -8.20 Mn |
| Jul 31, 2025 | -8.09 Mn |
| Apr 30, 2025 | -6.13 Mn |
| Jan 31, 2025 | -6.29 Mn |
| Oct 31, 2024 | -5.80 Mn |
| Jul 31, 2024 | 2.99 Mn |
| Apr 30, 2024 | 1.72 Mn |
| Jan 31, 2024 | -11.29 Mn |
| Oct 31, 2023 | -8.28 Mn |
| Jul 31, 2023 | -11.88 Mn |
| Apr 30, 2023 | -4.90 Mn |
| Jan 31, 2023 | -11.88 Mn |
| Oct 31, 2022 | -1.11 Mn |
| Jul 31, 2022 | 11.16 Mn |
| Apr 30, 2022 | -10.02 Mn |
| Jan 31, 2022 | -3.87 Mn |
| Oct 31, 2021 | -27.53 Mn |
| Jul 31, 2021 | -2.72 Mn |
API Access
BriaCell Therapeutics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();